- Home
- ATMU vs VKTX Comparison
ATMU vs VKTX Comparison
Compare ATMU & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATMU
- VKTX
- Stock Information
- Founded
- ATMU 1958
- VKTX 2012
- Country
- ATMU United States
- VKTX United States
- Employees
- ATMU N/A
- VKTX N/A
- Industry
- ATMU Auto Parts:O.E.M.
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- ATMU Consumer Discretionary
- VKTX Health Care
- Exchange
- ATMU Nasdaq
- VKTX Nasdaq
- Market Cap
- ATMU 3.3B
- VKTX 3.4B
- IPO Year
- ATMU 2023
- VKTX 2015
- Fundamental
- Price
- ATMU $34.81
- VKTX $24.22
- Analyst Decision
- ATMU Buy
- VKTX Strong Buy
- Analyst Count
- ATMU 5
- VKTX 11
- Target Price
- ATMU $42.80
- VKTX $95.18
- AVG Volume (30 Days)
- ATMU 1.1M
- VKTX 3.8M
- Earning Date
- ATMU 05-02-2025
- VKTX 04-23-2025
- Dividend Yield
- ATMU 0.43%
- VKTX N/A
- EPS Growth
- ATMU 8.29
- VKTX N/A
- EPS
- ATMU 2.22
- VKTX N/A
- Revenue
- ATMU $1,669,600,000.00
- VKTX N/A
- Revenue This Year
- ATMU $4.22
- VKTX N/A
- Revenue Next Year
- ATMU $5.80
- VKTX N/A
- P/E Ratio
- ATMU $15.59
- VKTX N/A
- Revenue Growth
- ATMU 2.55
- VKTX N/A
- 52 Week Low
- ATMU $27.62
- VKTX $23.27
- 52 Week High
- ATMU $45.43
- VKTX $81.86
- Technical
- Relative Strength Index (RSI)
- ATMU 35.36
- VKTX 37.29
- Support Level
- ATMU $36.18
- VKTX $23.27
- Resistance Level
- ATMU $37.93
- VKTX $29.60
- Average True Range (ATR)
- ATMU 1.09
- VKTX 1.57
- MACD
- ATMU -0.09
- VKTX -0.29
- Stochastic Oscillator
- ATMU 7.56
- VKTX 12.18
About ATMU Atmus Filtration Technologies Inc.
Atmus Filtration Technologies Inc manufactures filtration products for on-highway commercial vehicles and off-highway agriculture, construction, mining, and power generation vehicles and equipment. It designs and manufactures Developed filtration products, principally under the Fleetguard brand, that enable lower emissions and provide asset protection. It designs, manufactures, and sells filters, coolants, and chemical products. The company offers products for first-fit and aftermarket applications including air filters, fuel filters, fuel water separators, lube filters, hydraulic filters, coolants, fuel additives, and other filtration systems to original equipment manufacturers, dealers/distributors, and end-users.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.